Skip to main content

U.S. Clinical Oncology Next Generation Sequencing (NGS) Market to Significant Growth Foreseen by 2024

San Francisco, CA -- (SBWIRE) -- 12/18/2017 -- The segment is expected to grow further with the introduction of new tools such as NextSeq and MiniSeq platforms, which are likely to enhance the implement ability for a broad spectrum of research labs with varying sequencing needs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.